Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-067164
Filing Date
2017-11-09
Accepted
2017-11-09 07:33:17
Documents
74
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-20575_110q.htm 10-Q 1612380
2 EX-31.1 a17-20575_1ex31d1.htm EX-31.1 11922
3 EX-31.2 a17-20575_1ex31d2.htm EX-31.2 11283
4 EX-32.1 a17-20575_1ex32d1.htm EX-32.1 9186
  Complete submission text file 0001104659-17-067164.txt   7088468

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT neos-20170930.xml EX-101.INS 1265868
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT neos-20170930.xsd EX-101.SCH 66214
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT neos-20170930_cal.xml EX-101.CAL 51494
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT neos-20170930_def.xml EX-101.DEF 294786
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT neos-20170930_lab.xml EX-101.LAB 622040
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT neos-20170930_pre.xml EX-101.PRE 491835
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Filer) CIK: 0001467652 (see all company filings)

EIN.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37508 | Film No.: 171188266
SIC: 2834 Pharmaceutical Preparations